Your Molecule
Your Molecule
Small Molecule Sterile Injectables
Small Molecule Sterile Injectables
Robust formulations tailored for parenteral delivery — with a focus on solubility and long-term stability.
Early risk identification to design stable, patient-ready drug products
Small molecule therapeutics remain a cornerstone of modern medicine, providing a wide range of treatment options across oncology, cardiology, neurology, and infectious diseases. However, when these compounds are developed as sterile injectables, they face unique challenges that differ significantly from oral or topical dosage forms. Leukocare specializes in the stabilization and formulation of small molecules as sterile injectables—ensuring solubility, safety, chemical stability, and manufacturability from early development through global distribution.
Why small molecule injectables require special attention
Why small molecule injectables require special attention
Many small molecules present solubility limitations, chemical instability, or incompatibility with excipients. Without careful design, these molecules may precipitate, degrade under stress, or lose efficacy over time.
Furthermore, sterile injectables must withstand heat, light, pH variation, and mechanical stress during manufacturing, shipping, and storage. By systematically addressing these risks early, we help ensure that injectable small molecule formulations remain safe, stable, and effective across their lifecycle.
Explore our full modalities hub
Many small molecules present solubility limitations, chemical instability, or incompatibility with excipients. Without careful design, these molecules may precipitate, degrade under stress, or lose efficacy over time.
Furthermore, sterile injectables must withstand heat, light, pH variation, and mechanical stress during manufacturing, shipping, and storage. By systematically addressing these risks early, we help ensure that injectable small molecule formulations remain safe, stable, and effective across their lifecycle.
Explore our full modalities hub
Our expertise
Our expertise
Leukocare provides tailored formulation development to overcome solubility and stability hurdles. Our scientists combine formulation optimization with advanced analytical methods to design sterile injectable products that meet stringent regulatory and clinical requirements. Whether the challenge is low solubility, chemical degradation, or manufacturing scalability, our integrated development approach delivers solutions built for clinical and commercial success.
Leukocare provides tailored formulation development to overcome solubility and stability hurdles. Our scientists combine formulation optimization with advanced analytical methods to design sterile injectable products that meet stringent regulatory and clinical requirements. Whether the challenge is low solubility, chemical degradation, or manufacturing scalability, our integrated development approach delivers solutions built for clinical and commercial success.
Ready to talk about your bispecific formulation strategy?
Ready to talk about your bispecific formulation strategy?
Turning complex molecules into robust drug products
Key Focus Areas
-
Let’s Build the Right Formulation — Together
Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.
Let’s Build the Right Formulation — Together
Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.
How we support you
1. Feasibility assessment to identify solubility and stability risks early.
2. Optimization strategies guided by DoE and biostatistics for faster development.
3. Stability programs aligned with ICH Q1 requirements to support clinical trials and beyond.
4. Long-term partnership from early development through late-stage support, ensuring readiness for commercialization.